Between Jan 7 , 2010 , and Feb 22 , 2012 , we enrolled 1093 patients and randomly assigned them to receive necitumumab plus gemcitabine and cisplatin ( n = 545 ) or gemcitabine and cisplatin ( n = 548 ) .